Evox Therapeutics

Evox Therapeutics is a biotechnology company focused on harnessing and engineering the natural delivery capabilities of extracellular vesicles, known as exosomes, to develop a new class of therapeutics. The company's proprietary ExoEdit® platform enables the precise delivery of diverse therapeutic payloads, including proteins, nucleic acids, and gene-editing components, to previously inaccessible tissues, particularly within the central nervous system (CNS). Strategically focused on severe, genetically-driven neurodegenerative diseases, Evox aims to transform patient outcomes by addressing the root causes of conditions such as Huntington's disease, ALS, and Rett syndrome. By leveraging the modular nature of exosomes, the company seeks to overcome the limitations of traditional delivery methods like viral vectors and lipid nanoparticles, offering a safer, more potent, and scalable approach to genetic medicine.